Key Takeaways:
(P1) Boeing Co. (NYSE: BA) shares rose 4.6% after the aerospace giant reported first-quarter results that showed crucial production gains, even as Wall Street braced for a return to losses.
(P2) "The formal lifting of the 737 MAX production cap by the FAA in March was a critical step, allowing the company to target 47 aircraft per month by summer," said a Wells Fargo analyst in a recent note initiating coverage with an Overweight rating.
(P3) The company reported 143 commercial deliveries in the first quarter, surpassing Airbus's 114 for the first time since 2019. The 737 MAX program accounted for approximately 80% of these deliveries. Analysts had expected a loss of 66 cents per share on revenue of $22.0 billion for the quarter, a reversal from the surprise $9.92 per-share profit in the fourth quarter.
(P4) The positive stock reaction suggests investors are prioritizing production momentum over near-term profitability and program delays. The focus now shifts to whether Boeing can execute its 737 MAX ramp-up to 53 jets per month by year-end without further quality issues, a key factor for its free cash flow recovery.
The key to Boeing's recovery story is the successful ramp-up of its 737 MAX production. After the Federal Aviation Administration lifted the production cap in March, citing sustained quality improvements, Boeing has a clear path to increase output. This progress is crucial as the 737 MAX remains the company's primary cash cow. However, investors remain cautious after minor wiring issues paused some deliveries in March, seeking confirmation that quality control can keep pace with higher production rates.
The company's defense division also remains a significant contributor, delivering 30 aircraft in the first quarter. While this was an increase from 26 in the same period last year, it represented a sequential decline from 37 in the prior quarter.
Casting a shadow over the production gains is the continued delay of the 777X widebody program. With certification now expected to extend through 2026 and first deliveries potentially slipping into 2027, the program is a "large drag on FCF over the near term," according to Wells Fargo. While the long-term prospects of the 777X are promising, the near-term capital requirements weigh on investor sentiment. The market's positive reaction to the Q1 report indicates a willingness to look past these delays for now, focusing instead on the tangible progress in the 737 MAX line.
The report comes as competitor Northrop Grumman (NYSE: NOC) posted a 4.4% increase in first-quarter sales to $9.88 billion, driven by its Aeronautics Systems segment, highlighting the competitive landscape in the aerospace and defense sector.
The guidance for the remainder of 2026 will be critical for sustaining the stock's momentum. Investors will be watching the upcoming earnings call for management's commentary on free cash flow trajectory and any updates on the 777X timeline.
This article is for informational purposes only and does not constitute investment advice.
